Publicaciones en colaboración con investigadores/as de Catholic University of the Sacred Heart (22)

2023

  1. Emerging Trends and Future Directions in Skin Cancer Management

    Non-melanoma Skin Cancer: Essentials for Oncologists (CRC Press), pp. 407-426

  2. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆

    Annals of Oncology, Vol. 34, Núm. 10, pp. 833-848

  3. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

    Annals of Oncology, Vol. 34, Núm. 8, pp. 681-692

  4. Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer

    European Journal of Cancer, Vol. 189

2022

  1. Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative HDR brachytherapy

    Radiotherapy and Oncology, Vol. 170, pp. 159-164

2021

  1. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 12, pp. 1721-1731

  2. Prevalence of nodal involvement in rectal cancer after chemoradiotherapy

    The British journal of surgery, Vol. 108, Núm. 10, pp. 1251-1258

  3. Response to Escande et al.: Magnetic guided brachytherapy: Time for non-pelvic cancer? Example from tongue brachytherapy [1]

    Radiotherapy and Oncology

2019

  1. Adjuvant chemoradiation in pancreatic cancer: Impact of radiotherapy dose on survival

    BMC Cancer, Vol. 19, Núm. 1

  2. Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): Single institution experience and systematic literature review

    Journal of Contemporary Brachytherapy, Vol. 11, Núm. 1, pp. 54-60

  3. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis

    Translational Oncology, Vol. 12, Núm. 1, pp. 1-7

2015

  1. Adjuvant chemoradiation in pancreatic cancer: A pooled analysis in elderly (≥75 years) patients

    Anticancer Research, Vol. 35, Núm. 6, pp. 3441-3446

2014

  1. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 90, Núm. 4, pp. 911-917

  2. Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer)

    European Journal of Cancer

2013

  1. Clinical and technical characteristics of intraoperative radiotherapy: Analysis of the ISIORT-Europe database

    Strahlentherapie und Onkologie

  2. Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

    European Journal of Cancer, Vol. 49, Núm. 18, pp. 3831-3838

2011

  1. Primary Colorectal Cancer

    INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 297-322

  2. Recurrent Colorectal Cancer

    INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 323-351

2010

  1. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data

    The Lancet Oncology, Vol. 11, Núm. 9, pp. 835-844

  2. Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: Adjuvant chemotherapy prevents local recurrence rather than distant metastases

    Annals of Oncology, Vol. 21, Núm. 6, pp. 1279-1284